Cargando…

Viral infections of the respiratory tract in patients with cystic fibrosis

The role of viruses and bacteria in the development of respiratory tract infections causing acute deteriorations in lung function in patients with cystic fibrosis (CF) was investigated. Over a period of 30 months, 29 viral respiratory diseases were proven serologically by testing 275 sporadically co...

Descripción completa

Detalles Bibliográficos
Autores principales: Przyklenk, B., Bauernfeind, A., Bertele, R.M., Deinhardt, F., Harms, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1988
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148835/
http://dx.doi.org/10.1016/0888-0786(88)90057-1
_version_ 1783520680334065664
author Przyklenk, B.
Bauernfeind, A.
Bertele, R.M.
Deinhardt, F.
Harms, K.
author_facet Przyklenk, B.
Bauernfeind, A.
Bertele, R.M.
Deinhardt, F.
Harms, K.
author_sort Przyklenk, B.
collection PubMed
description The role of viruses and bacteria in the development of respiratory tract infections causing acute deteriorations in lung function in patients with cystic fibrosis (CF) was investigated. Over a period of 30 months, 29 viral respiratory diseases were proven serologically by testing 275 sporadically collected sera from 75 patients with cystic fibrosis. The influenza A virus was the most frequent responsible viral pathogen (11 × ), followed by adenovirus (8 × ), influenza B virus (5 × ), parainfluenza virus type 3 (3 × ), parainfluenza virus type 1 and respiratory syncytial virus (RSV) (each of 1 × ). There was no serological evidence for infections with parainfluenza virus type 2, Mycoplasma pneumoniae or Coxiella burnetii. Deterioration of the clinical condition was found in 78% of the viral infections leading in 70% to hospital admission. Patients with cystic fibrosis and viral respiratory illnesses showed significantly more admissions to the hospital (3·2 ± 2·7) with a longer stay (90·6 ± 99·6 days). Nearly all viral episodes (93%) were accompanied or followed by a significant change of the microbial flora in the sputum especially by colonisation with Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae. Seventy-two per cent of the viral infections occurred at home and 28% seemed to be hospital acquired. Our study emphasises the importance of improving antibacterial therapy at home to reduce the number of hospital admissions. Efforts for prophylaxis by vaccination or the use of chemotherapeutic agents should be made for the patients with cystic fibrosis.
format Online
Article
Text
id pubmed-7148835
institution National Center for Biotechnology Information
language English
publishDate 1988
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71488352020-04-13 Viral infections of the respiratory tract in patients with cystic fibrosis Przyklenk, B. Bauernfeind, A. Bertele, R.M. Deinhardt, F. Harms, K. Serodiagnosis and Immunotherapy in Infectious Disease Article The role of viruses and bacteria in the development of respiratory tract infections causing acute deteriorations in lung function in patients with cystic fibrosis (CF) was investigated. Over a period of 30 months, 29 viral respiratory diseases were proven serologically by testing 275 sporadically collected sera from 75 patients with cystic fibrosis. The influenza A virus was the most frequent responsible viral pathogen (11 × ), followed by adenovirus (8 × ), influenza B virus (5 × ), parainfluenza virus type 3 (3 × ), parainfluenza virus type 1 and respiratory syncytial virus (RSV) (each of 1 × ). There was no serological evidence for infections with parainfluenza virus type 2, Mycoplasma pneumoniae or Coxiella burnetii. Deterioration of the clinical condition was found in 78% of the viral infections leading in 70% to hospital admission. Patients with cystic fibrosis and viral respiratory illnesses showed significantly more admissions to the hospital (3·2 ± 2·7) with a longer stay (90·6 ± 99·6 days). Nearly all viral episodes (93%) were accompanied or followed by a significant change of the microbial flora in the sputum especially by colonisation with Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae. Seventy-two per cent of the viral infections occurred at home and 28% seemed to be hospital acquired. Our study emphasises the importance of improving antibacterial therapy at home to reduce the number of hospital admissions. Efforts for prophylaxis by vaccination or the use of chemotherapeutic agents should be made for the patients with cystic fibrosis. Published by Elsevier B.V. 1988-06 2004-11-15 /pmc/articles/PMC7148835/ http://dx.doi.org/10.1016/0888-0786(88)90057-1 Text en Copyright © 1988 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Przyklenk, B.
Bauernfeind, A.
Bertele, R.M.
Deinhardt, F.
Harms, K.
Viral infections of the respiratory tract in patients with cystic fibrosis
title Viral infections of the respiratory tract in patients with cystic fibrosis
title_full Viral infections of the respiratory tract in patients with cystic fibrosis
title_fullStr Viral infections of the respiratory tract in patients with cystic fibrosis
title_full_unstemmed Viral infections of the respiratory tract in patients with cystic fibrosis
title_short Viral infections of the respiratory tract in patients with cystic fibrosis
title_sort viral infections of the respiratory tract in patients with cystic fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148835/
http://dx.doi.org/10.1016/0888-0786(88)90057-1
work_keys_str_mv AT przyklenkb viralinfectionsoftherespiratorytractinpatientswithcysticfibrosis
AT bauernfeinda viralinfectionsoftherespiratorytractinpatientswithcysticfibrosis
AT bertelerm viralinfectionsoftherespiratorytractinpatientswithcysticfibrosis
AT deinhardtf viralinfectionsoftherespiratorytractinpatientswithcysticfibrosis
AT harmsk viralinfectionsoftherespiratorytractinpatientswithcysticfibrosis